You are here

Synjardy

FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes

Benzinga

Tue, 06/20/23 - 09:46 pm

Boehringer Ingelheim

type 2 diabetes

CHMP Issues Positive Opinion to Expand Labeling of Jardiance, Synjardy and Glyxambi to Include Positive Effects on Cardiovascular and Renal Outcomes

CP Wire

Mon, 07/2/18 - 10:02 am

Boehringer Ingelheim

CHMP Issues Positive Opinion to Expand Labeling of Jardiance, Synjardy and Glyxambi to Include Positive Effects on Cardiovascular and Renal Outcomes

Mon, 07/2/18 - 09:26 am

Boehringer Ingelheim

U.S. FDA expands indication for type 2 diabetes treatment Synjardy to include treatment-naïve adults

Yahoo

Wed, 07/20/16 - 02:25 pm

type 2 diabetes